Abstract
We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVHD.
| Original language | English |
|---|---|
| Pages (from-to) | 1141-1144 |
| Number of pages | 4 |
| Journal | Bone Marrow Transplantation |
| Volume | 54 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 1 Jul 2019 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Tyrosine kinase inhibitor levels matter in treating chronic GVHD'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver